October 4 2022October 20, 2022 by ICS Developers Dr. Sid Kerkar speaks with CGT Live about how EXUMA’s TaNK platforms aim to make CAR therapy safer and faster through novel lentivector engineeringThe Vice President of Research & Development, Oncology at Exuma Biotech discussed the company’s platforms, including CAR-TaNK cells. Click here to read the full article